You are here: Industry Insights > Inhaler

News List

Only Four in 10 With Severe Asthma See Specialist drugs
July 01, 2021
Specialist care for severe asthma is underutilized, with fewer than four in 10 patients with severe asthma seeking care, according to a study published online June 17 in the Journal of Allergy and Clinical Immunology: In Practice.
Chiesi launches pilot inhaler recycling scheme in the UK pharmatimes
February 20, 2021
Italian pharma company Chiesi has launched a pilot scheme in Leicestershire, UK which will aim to make disposing of and recycling inhalers easier.
As-Needed Inhaler Use an Option for Children With Mild Asthma drugs
August 26, 2019
Children with mild asthma can use inhalers as needed, according to a study published online in the Journal of Allergy and Clinical Immunology: In Practice.
Hovione Acquires Rights For Inhaler Device contractpharma
April 16, 2019
Affordable, multi-use blister-based dry powder inhaler will be marketed as the Papillon DPI.
Researchers develop new treatment for TB pharmaceutical-technology
January 10, 2019
A team of researchers has developed a novel treatment for tuberculosis (TB), which has the potential to be ‘scaled-up’ for clinical testing.....
AZ’s new COPD inhaler Bevespi Aerosphere approved in EU pharmaphorum
December 24, 2018
AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive pulmonary disease (COPD).
Inhaler delivers cannabinoids faster at lower doses europeanpharmaceuticalreview
September 27, 2018
Researchers have released data on a clinical trial using specific inhalers and oral capsules to deliver cannabinoids to participants…
AZ’s triple therapy inhaler hits 8 out of 9 endpoints pharmafile
January 29, 2018
AstraZeneca has made a brief announcement that its triple therapy inhaler manage to successfully hit eight of nine primary endpoints in the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD).
Teva gets FDA approval for easier-to-use inhaler pharmatimes
August 08, 2017
The FDA has approved Teva’s QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the maintenance treatment of asthma.
H&T Presspart, Hovione Technology Enter DPI Pact contractpharma
April 28, 2017
Provides access to Hovione’s API formulation and manufacturing services for new capsule-based dry powder inhaler

Previous page 1 2 Next page